The magnetic resonance imaging (MRI) coils market is experiencing significant growth due to the escalating prevalence of chronic diseases worldwide. Chronic conditions such as cancer, cardiovascular diseases, and neurological disorders necessitate accurate and non-invasive diagnostic tools, with MRI coils playing a pivotal role.
For instance, in 2020, the American Heart Association (AHA) disclosed a significant global burden of cardiovascular disease (CVD), reporting 19.1 million deaths with an age-adjusted death rate of 239.8 per 100,000 and an age-adjusted prevalence rate of 7354.1 per 100,000. This highlights the substantial impact of CVD on public health.
MRI and specialized RF coils are valuable tools for the assessment and understanding of cardiovascular disorders, aiding in the visualization and characterization of structural and functional changes in heart, and other organs, thereby propelling market growth in response to the escalating global incidence of these conditions.
Authors:
Mariam Faizullabhoy , Pratiksha Kamthe
Frequently Asked Questions (FAQ) :
Magnetic resonance imaging coils industry was valued at USD 8.8 billion in 2023 and will exhibit 7.6% CAGR from 2024 to 2032, attributed to increasing prevalence of chronic diseases and the rising demand for accurate diagnostic imaging.
The neurology segment in the market will garner 7.6% CAGR through 2032, owing to the high prevalence of neurological disorders, such as Alzheimer's, Parkinson's, and multiple sclerosis.
North America magnetic resonance imaging coils industry will record 7.4% CAGR between 2024 and 2032, fueled by the rising prevalence of chronic diseases, and high adoption of cutting-edge medical technologies.
Canon Medical Systems Corporation, Esaote SPA, GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Scanmed, LLC., Siemens Healthineers AG, Magnetica Ltd. (AVINGTRANS PLC), MR Instruments, Inc., Rapid MR international, LLC., and Tesla Engineering Ltd. (Tesla Ltd.), among others.